Alison L. Hannah Neogenomics Inc (NEO) insider trading activity

NEO Quotes by TradingView

Alison L. Hannah is Director of NEOGENOMICS INC. Currently has a direct ownership of 131,023 shares of NEO, which is worth approximately $934,193. The most recent transaction as insider was on Jun 01, 2025, when has been sold 12,254 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 131K
10.32% 3M change
21.96% 12M change
Total Value Held $934,193

ALISON L. HANNAH Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 01 2025
BUY
Grant, award, or other acquisition
-
12,254 Added 8.55%
131,023 Common Stock
Aug 10 2024
BUY
Exercise of conversion of derivative security
-
11,336 Added 8.71%
118,769 Common Stock
Jun 10 2022
BUY
Grant, award, or other acquisition
-
15,556 Added 12.65%
107,433 Common Stock
Jun 02 2021
BUY
Grant, award, or other acquisition
-
3,081 Added 3.24%
91,877 Common Stock

Also insider at

CTMX
CytomX Therapeutics, Inc. Healthcare
Chief Medical Officer
RIGL
RIGEL PHARMACEUTICALS INC Healthcare
ALH

Alison L. Hannah

Director
South San Francisco, CA

Track Institutional and Insider Activities on NEO

Follow NEOGENOMICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NEO shares.

Notify only if

Insider Trading

Get notified when an Neogenomics Inc insider buys or sells NEO shares.

Notify only if

News

Receive news related to NEOGENOMICS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NEO